Moleculin Biotech, Inc.·4

Jun 21, 5:01 PM ET

PICKER DONALD H 4

4 · Moleculin Biotech, Inc. · Filed Jun 21, 2024

Insider Transaction Report

Form 4
Period: 2024-06-20
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2024-06-201,07828,124 total
    Common Stock (1,078 underlying)
  • Exercise/Conversion

    Common Stock

    2024-06-20+1,0787,079 total
  • Tax Payment

    Common Stock

    2024-06-20$3.78/sh320$1,2106,759 total
Footnotes (3)
  • [F1]Restricted stock units convert into common stock on a one-for-one basis.
  • [F2]Shares withheld for payment of taxes upon vesting of restricted stock unit awards.
  • [F3]On June 20, 2022, the reporting person was granted 4,312 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4